Prime Medicine, Inc.
PRME
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Revenues | 6.0 | 3.0 | 0.0 | 5.2 | 0.0 | 5.2 | |
| Cost of Revenues | 45.9 | 0.0 | 147.9 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | -39.9 | 3.0 | -147.9 | 5.2 | 0.0 | 5.2 | |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 147.9 | 86.7 | 70.6 | 3.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 38.7 | 29.8 | 13.9 | 3.2 | |
| Depreciation & Amortization | 7.2 | 6.1 | 4.7 | 8.1 | 1.0 | -10.8 | |
| Total Operating Expenses | 164.1 | 205.5 | 186.6 | 116.5 | 84.5 | 6.1 | |
| Operating Income | -204.0 | -202.5 | -191.3 | -116.5 | -84.5 | -0.9 | |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Interest Income | 5.1 | 3.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 12.1 | 0.0 | 0.0 | |
| Other Expense | 6.6 | 6.6 | -7.1 | -6.2 | -81.4 | -0.6 | |
| IBT | -197.3 | -195.9 | -198.4 | -122.8 | -165.9 | -1.5 | |
| Income Tax Expense | 0.0 | 0.0 | -0.3 | -0.9 | -0.5 | 1.9 | |
| Net Income | -197.3 | -195.9 | -198.1 | -121.8 | -165.4 | -3.4 | |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-2.18 | $-3.59 | $-2.30 | $-0.05 | |
| EPS Diluted | $0.00 | $0.00 | $-2.18 | $-3.59 | $-2.30 | $-0.05 | |
| Shares Outstanding | 160.5 | 118.6 | 91.0 | 33.9 | 71.8 | 71.8 | |
| Diluted Shares Outstanding | 160.5 | 118.6 | 91.0 | 33.9 | 71.8 | 71.8 | |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 55.6 | 182.5 | 41.6 | 187.6 | 185.4 | 37.0 | |
| Short Term Investments | 107.3 | 8.0 | 80.1 | 106.3 | 84.2 | 16.4 | |
| Total Cash & ST Investments | 162.9 | 190.4 | 121.7 | 293.9 | 269.6 | 53.3 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 7.9 | 21.4 | 21.3 | 2.7 | 1.0 | 0.1 | |
| Total Current Assets | 170.8 | 211.9 | 143.0 | 293.9 | 270.6 | 53.4 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 75.4 | 71.6 | 36.6 | 48.6 | 15.7 | 0.6 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 13.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 14.1 | 14.3 | -52.8 | 15.6 | 0.8 | |
| Total Long-Term Assets | 88.9 | 85.6 | 50.9 | 66.4 | 31.3 | 1.4 | |
| Total Assets | 259.7 | 297.5 | 193.9 | 360.3 | 301.9 | 54.8 | |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.6 | 11.4 | 19.5 | 4.3 | 1.4 | 0.3 | |
| Short-Term Debt | 5.2 | 3.6 | 18.6 | 11.7 | 7.3 | 0.0 | |
| Other Current Liabilities | 16.1 | 15.9 | 18.3 | 10.7 | 12.3 | 19.2 | |
| Current Liabilities | 20.7 | 38.0 | 56.4 | 26.7 | 58.0 | 19.4 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 36.4 | 37.2 | 4.4 | 17.1 | 3.1 | 0.0 | |
| Capital Leases | 36.4 | 40.8 | 13.6 | 28.7 | 10.4 | 0.0 | |
| Def. Tax Liability | -6.0 | 0.0 | 0.0 | 0.3 | 1.2 | 1.9 | |
| Total Liabilities | 63.1 | 144.4 | 60.8 | 360.3 | 62.3 | 21.3 | |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -592.4 | -687.2 | -491.3 | -293.2 | -171.4 | -6.0 | |
| Comprehensive Income | -0.1 | 0.0 | 0.0 | -0.4 | 0.0 | 0.0 | |
| Total Common Equity | 196.6 | 153.1 | 133.1 | -293.6 | 239.6 | 33.5 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -217.4 | -195.9 | -198.1 | -121.8 | -165.4 | -3.4 | |
| Depreciation & Amortization | 5.3 | 6.1 | 4.7 | 2.2 | 0.6 | 0.0 | |
| Stock-Based Compensation | 21.9 | 26.1 | 13.9 | 6.5 | 1.7 | 0.4 | |
| Change Working Capital | -18.0 | 31.1 | 2.6 | -35.4 | 31.2 | 0.2 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -1.2 | -5.3 | 9.1 | 2.5 | 1.2 | 0.3 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 44.9 | 9.7 | 11.8 | 17.7 | 98.4 | -4.6 | |
| Cash from Operations | -196.2 | 0.0 | -165.4 | -131.8 | -34.1 | -5.5 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | -9.0 | -7.3 | -8.7 | -16.1 | -4.2 | -0.6 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -195.2 | -129.4 | -105.0 | -123.3 | -82.0 | 0.0 | |
| Sales of Investment | 177.6 | 204.2 | 132.6 | 93.0 | 13.0 | 0.0 | |
| Other Investing Activities | -25.9 | 0.0 | -0.2 | -0.7 | -0.5 | -0.4 | |
| Cash from Investing | -26.6 | 0.0 | 18.7 | -47.1 | -73.6 | -1.1 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | -6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 22.1 | 27.2 | -15.1 | 18.3 | 10.4 | 0.0 | |
| Issuance of Common Stock | 151.9 | 0.0 | 0.7 | 185.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 6.0 | 0.0 | 0.7 | -3.8 | 269.3 | 34.9 | |
| Cash from Financing | 157.9 | 0.0 | 0.7 | 181.5 | 269.3 | 34.9 | |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Change in Cash | -65.0 | 141.5 | -146.0 | 2.6 | 161.6 | 28.3 | |
| Closing Cash Balance | 55.6 | 196.5 | 55.1 | 201.1 | 198.5 | 37.0 | |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -205.2 | -130.2 | -174.1 | -147.9 | -38.2 | -6.2 | |
| Real Free Cash Flow | -227.1 | -156.2 | -188.0 | -154.4 | -40.0 | -6.6 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
